Integration Raises KRW 27.5 Bln for Korean Medicine

Seoul, South Korea - Integration said it raised KRW 27.5 billion (US$18.9 million) in a funding round led by Altos Ventures with participation from TBT.

The company operates Medistream, a platform for Korean medicine practitioners with approximately 23,700 members representing over 85 percent of registered Korean medicine doctors in South Korea, Integration said.

Founded in 2019 by CEO Jeong Hee-beom, the company has expanded into commerce operations for Korean medicine clinics and brands, as well as electronic medical record and customer relationship management services.

Integration's brand business generated KRW 45.4 billion (US$31.2 million) in revenue in 2024, a 73 percent increase from 2023, according to the company.

The Korean medicine clinic and hospital market is valued at approximately KRW 8 trillion with 96 million patient visits annually, Integration stated.

About 15,000 Korean medicine clinics operate in South Korea, predominantly as individual practices.

The company stated it focuses on operational efficiency in non-clinical functions, including distribution, marketing, and patient management.

The United States herbal medicine market is projected to grow at an annual rate exceeding 23 percent, the company said.

(US$1 = 1,454.00 won)